Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Chukwunonso K. Nwabufo, Omozojie P. Aigbogun, Kevin J.H Allen, Madeline N. Owens, Jeremy S. Lee, Christopher P. Phenix & Ed S. Krol. (2021) Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds. Xenobiotica 51:8, pages 885-900.
Read now
Read now
P. OLINGA, M. T. MEREMA, I. H. HOF, M. H. DE JAGER, K. P. DE JONG, M. J. H. SLOOFF, D. K. F. MEIJER & G. M. M. GROOTHUIS. (1998) Effect of cold and warm ischaemia on drug metabolism in isolated hepatocytes and slices from human and monkey liver. Xenobiotica 28:4, pages 349-360.
Read now
Read now
S. E. CLARKE. (1998) In vitro assessment of human cytochrome P450. Xenobiotica 28:12, pages 1167-1202.
Read now
Read now
Sean Ekins. (1996) Past, Present, and Future Applications of Precision-Cut Liver Slices for in Vitro Xenobiotic Metabolism. Drug Metabolism Reviews 28:4, pages 591-623.
Read now
Read now
Michael L. Gargas, Michele A. Medinsky & Melvin E. Andersen. (1995) Pharmacokinetic Modeling Approaches for Describing the Uptake, Systemic Distribution, and Disposition of Inhaled Chemicals. Critical Reviews in Toxicology 25:3, pages 237-254.
Read now
Read now
J. C. Bloomer, S. E. Clarke & R. J. Chenery. (1995) Determination of P4501A2 activity in human liver microsomes using [3-14C-methyl]caffeine. Xenobiotica 25:9, pages 917-927.
Read now
Read now
N. Rodopoulos, O. Wisen & A. Norman. (1995) Caffeine metabolism in patients with chronic liver disease. Scandinavian Journal of Clinical and Laboratory Investigation 55:3, pages 229-242.
Read now
Read now
Steven A. Wrighton, Mark Vandenbranden, Jeffrey C. Stevens, Lisa A. Shipley, Barbara J. Ring, John R. Cashman & Allan E. Rettie. (1993) In Vitro Methods for Assessing Human Hepatic Drug Metabolism: Their use in Drug Development. Drug Metabolism Reviews 25:4, pages 453-484.
Read now
Read now
F. Berthou, B. Guillois, C. Riche, Y. Dreano, E. Jacqz-Aigrain & P. H. Beaune. (1992) Interspecies variations in caffeine metabolism related to cytochrome P4501A enzymes. Xenobiotica 22:6, pages 671-680.
Read now
Read now
Articles from other publishers (69)
Gözde Gürdeniz, Matti Uusitupa, Kjeld Hermansen, Markku J. Savolainen, Ursula Schwab, Marjukka Kolehmainen, Lea Brader, Lieselotte Cloetens, Karl-Heinz Herzig, Janne Hukkanen, Fredrik Rosqvist, Stine Marie Ulven, Ingibjörg Gunnarsdóttir, Inga Thorsdottir, Matej Oresic, Kaisa S. Poutanen, Ulf Risérus, Björn Åkesson & Lars Ove Dragsted. (2022) Analysis of the SYSDIET Healthy Nordic Diet randomized trial based on metabolic profiling reveal beneficial effects on glucose metabolism and blood lipids. Clinical Nutrition 41:2, pages 441-451.
Crossref
Crossref
Dagmar Bury, Camilla Alexander-White, Harvey J. ClewellIIIIII, Mark Cronin, Bertrand Desprez, Ann Detroyer, Alina Efremenko, James Firman, Eric Hack, Nicola J. Hewitt, Gerry Kenna, Martina Klaric, Cathy Lester, Catherine Mahony, Gladys Ouedraogo, Alicia Paini & Andreas Schepky. (2021) New framework for a non-animal approach adequately assures the safety of cosmetic ingredients – A case study on caffeine. Regulatory Toxicology and Pharmacology 123, pages 104931.
Crossref
Crossref
Joan Eilstein, Sébastien Grégoire, Aurélie Fabre, Eric Arbey, Camille Géniès, Hélène Duplan, Helga Rothe, Corie Ellison, Richard Cubberley, Andreas Schepky, Daniela Lange, Martina Klaric, Nicola J. Hewitt & Carine Jacques‐Jamin. (2020) Use of human liver and EpiSkin™ S9 subcellular fractions as a screening assays to compare the in vitro hepatic and dermal metabolism of 47 cosmetics‐relevant chemicals. Journal of Applied Toxicology 40:3, pages 416-433.
Crossref
Crossref
Camille Géniès, Carine Jacques‐Jamin, Hélène Duplan, Helga Rothe, Corie Ellison, Richard Cubberley, Andreas Schepky, Daniela Lange, Martina Klaric, Nicola Jane Hewitt, Sébastien Grégoire, Eric Arbey, Aurélie Fabre & Joan Eilstein. (2019) Comparison of the metabolism of 10 cosmetics‐relevant chemicals in EpiSkin™ S9 subcellular fractions and in vitro human skin explants. Journal of Applied Toxicology 40:2, pages 313-326.
Crossref
Crossref
C. Géniès, E. L. Jamin, L. Debrauwer, D. Zalko, E. N. Person, J. Eilstein, S. Grégoire, A. Schepky, D. Lange, C. Ellison, A. Roe, S. Salhi, R. Cubberley, N. J. Hewitt, H. Rothe, M. Klaric, H. Duplan & C. Jacques‐Jamin. (2018) Comparison of the metabolism of 10 chemicals in human and pig skin explants. Journal of Applied Toxicology.
Crossref
Crossref
R.S. Settivari, J.C. Rowlands, D.M. Wilson, S.M. Arnold & P.J. Spencer. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
843
873
.
Edward W. Carney & Raja Settivari. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
777
806
.
Stéphanie Madec, Virginie Cerec, Emmanuelle Plée-Gautier, Joseph Antoun, Denise Glaise, Jean-Pierre Salaun, Christiane Guguen-Guillouzo & Anne Corlu. (2011) CYP4F3B Expression Is Associated with Differentiation of HepaRG Human Hepatocytes and Unaffected by Fatty Acid Overload. Drug Metabolism and Disposition 39:10, pages 1987-1996.
Crossref
Crossref
Hilde BohetsClaude McGowanGeert MannensNathalie SchroederKimberly Edwards-SwansonAron Shapiro. (2011) Clinical Pharmacology of Alcaftadine, a Novel Antihistamine for the Prevention of Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics 27:2, pages 187-195.
Crossref
Crossref
Andreas K. Nussler, Natascha C. Nussler, Vera Merk, Marc Brulport, Wiebke Schormann, Ping Yao & Jan G. Hengstler. 2009. Strategies in Regenerative Medicine. Strategies in Regenerative Medicine
1
38
.
Takashi Katsu, Yumi Tsunamoto, Nobumitsu Hanioka, Keiko Komagoe, Kazufumi Masuda & Shizuo Narimatsu. (2008) A caffeine-sensitive membrane electrode: Previous misleading report and present approach. Analytica Chimica Acta 620:1-2, pages 50-54.
Crossref
Crossref
Sofia Pavanello, Alessandra Pulliero, Silvia Lupi, Pasquale Gregorio & Erminio Clonfero. (2005) Influence of the genetic polymorphism in the 5′-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 587:1-2, pages 59-66.
Crossref
Crossref
Fabiola Castorena-Torres, Ania Mendoza-Cantú, Mario Bermúdez de León, Bulmaro Cisneros, Omar Zapata-Pérez, Lizbeth López-Carrillo, Juan E. Salinas & Arnulfo Albores. (2005) CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, Mexico. Toxicology Letters 156:3, pages 331-339.
Crossref
Crossref
Valérie Le Quéré, Emmanuelle Plée-Gautier, Philippe Potin, Stéphanie Madec & Jean-Pierre Salaün. (2004) Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. Journal of Lipid Research 45:8, pages 1446-1458.
Crossref
Crossref
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
Crossref
S Pavanello, P Simioli, G Mastrangelo, S Lupi, G Gabbani, P Gregorio & E Clonfero. (2002) Role of metabolic polymorphisms NAT2 and CYP1A2 on urinary mutagenicity after a pan-fried hamburger meal. Food and Chemical Toxicology 40:8, pages 1139-1144.
Crossref
Crossref
Y Amet, F Adas & F Berthou. (2002) High performance liquid chromatography of fatty acid metabolites. Analytica Chimica Acta 465:1-2, pages 193-198.
Crossref
Crossref
Florence Grand, Izzet Kilinc, Albert Sarkis & Jérôme Guitton. (2002) Application of Isotopic Ratio Mass Spectrometry for the in Vitro Determination of Demethylation Activity in Human Liver Microsomes Using N-methyl-13C-Labeled Substrates. Analytical Biochemistry 306:2, pages 181-187.
Crossref
Crossref
Virginie Charasson, Marie-Christine Haaz & Jacques Robert. (2002) Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan: Figure 1. Drug Metabolism and Disposition 30:6, pages 731-733.
Crossref
Crossref
Andreas Labedzki, Jeroen Buters, Wafaâ Jabrane & Uwe Fuhr. (2002) Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2. Biochemical Pharmacology 63:12, pages 2159-2167.
Crossref
Crossref
Marie-Sophie Caubet, Walid Elbast, Marie-Claude Dubuc & Jean-Louis Brazier. (2002) Analysis of urinary caffeine metabolites by HPLC-DAD: the use of metabolic ratios to assess CYP1A2 enzyme activity. Journal of Pharmaceutical and Biomedical Analysis 27:1-2, pages 261-270.
Crossref
Crossref
Annabelle Le Gal, Yvonne Dréano, Pier-Giovanni Gervasi & François Berthou. (2001) Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers used as oxyfuels. Toxicology Letters 124:1-3, pages 47-58.
Crossref
Crossref
H Bohets, K Lavrijsen, J Hendrickx, J Van Houdt, V Van Genechten, P Verboven, W Meuldermans & J Heykants. (2009)
Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride:
in vitro
studies of potential co‐medication interactions
. British Journal of Pharmacology 129:8, pages 1655-1667.
Crossref
Crossref
Ute Jorritsma, Eberhard Schrader, Götz Klaunick, Jaime Kapitulnik, Karen I. Hirsch-Ernst, Georg F. Kahl & Heidi Foth. (2000) Monitoring of cytochrome P-450 1A activity by determination of the urinary pattern of caffeine metabolites in Wistar and hyperbilirubinemic Gunn rats. Toxicology 144:1-3, pages 229-236.
Crossref
Crossref
G. Gabbani, S. Pavanello, P. Simioli, A. Bordin & E. Clonfero. 2000. Dietary Anticarcinogens and Antimutagens. Dietary Anticarcinogens and Antimutagens
410
411
.
T. Robinson. 2000. Bioactive Natural Products (Part C). Bioactive Natural Products (Part C)
3
54
.
F. Adas, J.P. Salaün, F. Berthou, D. Picart, B. Simon & Y. Amet. (1999) Requirement for ω and (ω–1)-hydroxylations of fatty acids by human cytochromes P450 2E1 and 4A11. Journal of Lipid Research 40:11, pages 1990-1997.
Crossref
Crossref
F Adas, F Berthou, J.P Salaün, Y Dréano & Y Amet. (1999) Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A. Toxicology Letters 110:1-2, pages 43-55.
Crossref
Crossref
Sandra CoeckeVera RogiersMartin BaylissJosé CastellJohannes DoehmerGérard FabreJeffrey FryArmin Kern & Carl Westmoreland. (2019) The use of Long-term Hepatocyte Cultures for Detecting Induction of Drug Metabolising Enzymes: The Current Status. Alternatives to Laboratory Animals 27:4, pages 579-638.
Crossref
Crossref
Sean Ekins, Jukka Maenpää & Steven Wrighton. 1999. Handbook of Drug Metabolism. Handbook of Drug Metabolism
363
399
.
Dirce Mithico Yamaoka-Yano & Paulo Mazzafera. (1999) Catabolism of caffeine and purification of a xanthine oxidade responsible for methyluric acids production in Pseudomonas putida L. Revista de Microbiologia 30:1, pages 62-70.
Crossref
Crossref
Yolande Amet, Fadi Adas & Amin A. Nanji. (2006) Fatty Acid ω‐ and (ω‐1)‐Hydroxylation in Experimental Alcoholic Liver Disease: Relationship to Different Dietary Fatty Acids. Alcoholism: Clinical and Experimental Research 22:7, pages 1493-1500.
Crossref
Crossref
F Adas, D Picart, F Berthou, B Simon & Y Amet. (1998) Liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of ω- and (ω-1)-hydroxylated metabolites of elaidic and oleic acids in human and rat liver microsomes. Journal of Chromatography B: Biomedical Sciences and Applications 714:2, pages 133-144.
Crossref
Crossref
Fadi Adas, François Berthou, Daniel Picart, Patrick Lozac'h, Françoise Beaugé & Yolande Amet. (1998) Involvement of cytochrome P450 2E1 in the (ω–1)-hydroxylation of oleic acid in human and rat liver microsomes. Journal of Lipid Research 39:6, pages 1210-1219.
Crossref
Crossref
Alain Zerilli, Daniele Lucas, Yvonne Dreano, Daniel Picart & Francois Berthou. (1998) Effect of Pyrazole and Dexamethasone Administration on Cytochrome P450 2E1 and 3A Isoforms in Rat Liver and Kidney: Lack of Specificity of p-Nitrophenol as a Substrate of P450 2E1. Alcoholism: Clinical and Experimental Research 22:3, pages 652-657.
Crossref
Crossref
Keiichi Morita, Yutaka Maeda, Makihiko Masuda, Akio Kazusaka, Susumu Imaoka, Yoshihiko Funae & Shoichi Fujita. (1998) Strain Differences in CYP3A-Mediated C-8 Hydroxylation (1,3,7-Trimethyluric Acid Formation) of Caffeine in Wistar and Dark Agouti Rats. Biochemical Pharmacology 55:9, pages 1405-1411.
Crossref
Crossref
Yolande Amet, Danièle Lucas, Zhi‐Qi Zhang‐Gouillon & Samuel W. French. (2006) P‐450 ‐Dependent Metabolism of Laurie Acid in Alcoholic Liver Disease: Comparison between Rat Liver and Kidney Microsomes. Alcoholism: Clinical and Experimental Research 22:2, pages 455-462.
Crossref
Crossref
Yolande Amet, Alain Zerilli, Thierry Goasduff, Yvonne Dréano & François Berthou. (1997) Noninvolvement of CYP2E1 in the (ω-1)-hydroxylation of fatty acids in rat kidney microsomes. Biochemical Pharmacology 54:8, pages 947-952.
Crossref
Crossref
Gwénaëlle Bellec, Yvonne Dréano, Jean-Pierre Bail, Jean-François Ménez & François Berthou. (1997) Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 377:2, pages 199-209.
Crossref
Crossref
Yolande Amet, François Berthou, Georges Fournier, Yvonne Dréano, Louis Bardou, Jacques Clèdes & Jean-François Ménez. (1997) Cytochrome P450 4A and 2E1 expression in human kidney microsomes. Biochemical Pharmacology 53:6, pages 765-771.
Crossref
Crossref
Marie‐Christine Haaz, Laurent Rivory, Sophie Jantet, Damrong Ratanasavanh & Jacques Robert. (2009) Glucuronidation of SN‐38, the Active Metabolite of Irinotecan, by Human Hepatic Microsomes. Pharmacology & Toxicology 80:2, pages 91-96.
Crossref
Crossref
P. Olinga, D.K.F. Meijer, M.J.H. Slooff & G.M.M. Groothuis. (1997) Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue. Toxicology in Vitro 12:1, pages 77-100.
Crossref
Crossref
MARÍA JOSÉ GÓMEZ-LECHÓN, TERESA DONATO, XAVIER PONSODA, RICARDO FABRA, RAMÓN TRULLENQUE & JOSÉ V. CASTELL. 1997. In Vitro Methods in Pharmaceutical Research. In Vitro Methods in Pharmaceutical Research
129
153
.
Thierry Goasduff, Yvonne Dréano, Bernard Guillois, Jean-François Menez & François Berthou. (1996) Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochemical Pharmacology 52:12, pages 1915-1919.
Crossref
Crossref
Gwénaëlle Bellec, Yvonne Dreano, Roger Pichon, Jean-François Ménez & François Berthou. (1996) Hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by rat liver microsomes. Cancer Letters 108:2, pages 171-178.
Crossref
Crossref
Y. Amet, F. Berthou & J.F. Menez. (1996) Simultaneous radiometric and fluorimetric detection of lauric acid metabolites using high-performance liquid chromatography following esterification with 4-bromomethyl-6,7-dimethoxycoumarin in human and rat liver microsomes. Journal of Chromatography B: Biomedical Sciences and Applications 681:2, pages 233-239.
Crossref
Crossref
Thierry Goasduff, Gwénaëlle Bellec, Yolande Amet, Yvonne Dreano, Jean François Menez & François Berthou. (1996) P450 2E1 expression in liver, kidney, and lung of rats treated with single or combined inducers. Alcohol 13:3, pages 301-308.
Crossref
Crossref
Gwenaëlle Bellec, Thierry Goasduff, Yvonne Dreano, Jean-François Menez & François Berthou. (1996) Effect of the length of alkyl chain on the cytochrome P450 dependent metabolism of N-dialkylnitrosamines. Cancer Letters 100:1-2, pages 115-123.
Crossref
Crossref
G. Gordon Gibson & Paul SkettG. Gordon Gibson & Paul Skett. 1994. Introduction to Drug Metabolism. Introduction to Drug Metabolism
180
216
.
Y. Amet, F. Berthou, S. Baird, Y. Dreano, J.P. Bail & J.F. Menez. (1995) Validation of the (ω-l)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Biochemical Pharmacology 50:11, pages 1775-1782.
Crossref
Crossref
Alan R. Parrish, A.Jay Gandolfi & Klaus Brendel. (1995) Precision-cut tissue slices: Applications in pharmacology and toxicology. Life Sciences 57:21, pages 1887-1901.
Crossref
Crossref
A. Bouraoui, J. L. Brazier, H. Zouaghi, B. Ribon, E. Vermeulen & M. Desage. (1995) Effects of capsaicinoids on oxidative metabolism of caffeine in isolated rat hepatocytes. European Journal of Drug Metabolism and Pharmacokinetics 20:3, pages 179-184.
Crossref
Crossref
François Berthou, Thierry Goasduff, Yvonne Dréano & Jean-François Ménez. (1995) Caffeine increases its own metabolism through cytochrome P4501A induction in rats. Life Sciences 57:6, pages 541-549.
Crossref
Crossref
C. Cazeneuve, G. Pons, E. Rey, JM Treluyer, T. Cresteil, G. Thiroux, P. D'Athis & G. Olive. (2012) Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.. British Journal of Clinical Pharmacology 37:5, pages 405-412.
Crossref
Crossref
François Berthou, Yvonne Dreano, Claire Belloc, Lauri Kangas, Jean-Charles Gautier & Philippe Beaune. (1994) Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Biochemical Pharmacology 47:10, pages 1883-1895.
Crossref
Crossref
Imre Klebovich, Pentti Arvela & Olavi Pelkonen. (1993) HPLC method for rapid determination of acetylator phenotype by measuring urinary caffeine metabolites. Journal of Pharmaceutical and Biomedical Analysis 11:10, pages 1017-1021.
Crossref
Crossref
André Guillouzo, Fabrice Morel, Olivier Fardel & Bernard Meunier. (1993) Use of human hepatocyte cultures for drug metabolism studies. Toxicology 82:1-3, pages 209-219.
Crossref
Crossref
Uwe Fuhr, Johannes Doehmer, Narayana Battula, Catherine Wölfel, Ingrid Flick, Christine Kudla, Yango Keita & A.Horst Staib. (1993) Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones. Toxicology 82:1-3, pages 169-189.
Crossref
Crossref
Danièle Lucas, François Berthou, Yvonne Dréano, Patrick Lozac'h, Alain Volant & Jean‐François Ménez. (2006) Comparison of Levels of Cytochromes P‐450, CYP1A2, CYP2E1, and Their Related Monooxygenase Activities in Human Surgical Liver Samples. Alcoholism: Clinical and Experimental Research 17:4, pages 900-905.
Crossref
Crossref
Paul M. Vancutsem & John G. Babish. (1993) Effects of ciprofloxacin and enrofloxacin on zoxazolamine kinetics, plasma concentration and sleeping times in mice. Toxicology Letters 69:1, pages 1-14.
Crossref
Crossref
John MAPOLES, Francois BERTHOU, Alice ALEXANDER, Francis SIMON & Jean-Francois MENEZ. (1993) Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression. European Journal of Biochemistry 214:3, pages 735-745.
Crossref
Crossref
T. Bienvenu, G. Pons, E. Rey, G. Thiroux & G. Olive. (1993) Effect of pregnandiol on caffeine metabolism in female rats. European Journal of Drug Metabolism and Pharmacokinetics 18:2, pages 181-185.
Crossref
Crossref
V. Kerlan, Y. Dreano, J.P. Bercovici, P.H. Beaune, H.H. Floch & F. Berthou. (1992) Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochemical Pharmacology 44:9, pages 1745-1756.
Crossref
Crossref
Uwe fuhr, Johannes Doehmer, Narayana Battula, Catherine Wölfel, Christine Kudla, Yango Keita & A.Horst Staib. (1992) Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Biochemical Pharmacology 43:2, pages 225-235.
Crossref
Crossref
Françoise Jacolot, Isabelle Simon, Yvonne Dreano, Philippe Beaune, Christian Riche & François Berthou. (1991) Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochemical Pharmacology 41:12, pages 1911-1919.
Crossref
Crossref
Pascal Le Corre, Damrong Ratanasavanh, François Chevanne, Denis Gibassier, Pierre Sado, Roger Le Verge & André Guillouzo. (2004) In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: Comparison with in vivo data. Chirality 3:5, pages 405-411.
Crossref
Crossref
Gabriel A. Kyerematen, Monica Morgan, Genevieve Warner, Louis F. Martin & Elliot S. Vesell. (1990) Metabolism of nicotine by hepatocytes. Biochemical Pharmacology 40:8, pages 1747-1756.
Crossref
Crossref
Y. Benchekroun, M. Desage, B. Ribon & J.L. Brazier. (1990) Gas chromatographic—mass spectrometric quantitation of tri-, di- and monomethylxanthines and uric acids from hepatocyte incubation media. Journal of Chromatography B: Biomedical Sciences and Applications 532, pages 261-275.
Crossref
Crossref
D. Ratanasavanh, F. Berthou, Y. Dreano, P. Mondlne, A. Guillouzo & C. Riche. (1990) Methylcholanthrene but not phenobarbital enhances caffeine and theophylline metabolism in cultured adult human hepatocytes. Biochemical Pharmacology 39:1, pages 85-94.
Crossref
Crossref